High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU

Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel, Alexandre Salé, Baptiste Arnouat, Jean-Louis Bizec, Marie Langelot, Christine Lineau, David Marquette, Françoise Martin, Mathieu Lederlin, Stéphane Jouneau

Source: Eur Respir J, 56 (5) 2001154; 10.1183/13993003.01154-2020
Journal Issue: November
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel, Alexandre Salé, Baptiste Arnouat, Jean-Louis Bizec, Marie Langelot, Christine Lineau, David Marquette, Françoise Martin, Mathieu Lederlin, Stéphane Jouneau. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J, 56 (5) 2001154; 10.1183/13993003.01154-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-flow oxygen therapy in COPD patients: Optimised oxygen delivery
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013

Transtracheal oxygen therapy as an effective treatment in patients suffering from severe hypoxemia and with high flow oxygen requirement: Description of two cases
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011


High flow heliox therapy via nasal cannulae may be safe and more effective than conventional oxygen therapy in infants with respiratory distress: an in silico study
Source: Eur Respir J 2007; 30: Suppl. 51, 377s
Year: 2007

High-flow oxygen by nasal cannula: experience of an intensive care unit
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019

Our experience of 200 patients: Usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013

Apneic oxygenation via nasal prongs at 10 L/min prevents hypoxemia during tracheal intubation for elective surgery
Source: Annual Congress 2013 –Mechanical ventilation and weaning
Year: 2013

Experimental use of CPAP device for emergency high-flow nasal oxygen therapy
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


High-flow oxygen therapy is more effective and less expensive for bronchiolitis than standard low-flow oxygen therapy: A decision analysis
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
Source: Eur Respir Rev, 26 (145) 170028; 10.1183/16000617.0028-2017
Year: 2017



Continuous positive airway pressure, oxygen therapy or high-flow nasal oxygen therapy in patients with acute COVID-19 lung disease?
Source: Sleep and Breathing Conference 2021
Year: 2021


Overview of the role of high-flow nasal oxygen therapy in acute and chronic respiratory care: has it found its place versus NIV?
Source: Sleep and Breathing Conference 2021
Year: 2021


High-flow nasal cannula heated-humidified (HFNC) oxygen (O2) at 2 litres (lt)/kg/min versus low-flow O2 (up to 2lt/min) in pediatric emergency department (PED) and pediatric ward (PW) in infants with bronchiolitis who need O2 administration: A combined prospective randomized controlled and retrospective study: Preliminary results
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015


High-flow nasal cannula therapy versus standard pressure support non-invasive ventilation in treating adult patients with severe asthma exacerbation complicated with respiratory failure
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021

High flow nasal cannula in patients not suitable for invasive ventilation – are we missing an opportunity for palliative care?
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

Early non-invasive ventilation versus conventional oxygen therapy in immunocompromised patients with respiratory failure: a meta-analysis
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017

Benefits of high-flow nasal cannula oxygen therapy on exercise capacity following acute exacerbation in ILD patients
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020




High-flow nasal oxygen versus noninvasive positive airway pressure after surgery
Source: International Congress 2016 – Noninvasive ventilation versus high-flow nasal therapy for hypoxemic patients
Year: 2016


Experience with high-flow nasal oxygen therapy in COVID-19 patients on a regular internal medicine ward
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


Management of the COPD patient with chronic respiratory insufficiency: long-term oxygen therapy, invasive and non-invasive ventilation and other approaches
Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD
Year: 2004